Login to Your Account



FDA Panel Backs Epilepsy Drug, Despite its Vision Loss Risks

By Donna Young


Thursday, January 8, 2009
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription